The US FDA has warned Teva Pharmaceutical Industries about its facility in Godollo, Hungary over ongoing concerns about manufacturing operations.
Bespak has launched an auto-injector designed to deliver higher viscosity drug formulations.
Acura Pharmaceuticals has licensed rights to use it anti-abuse technology to develop drug formulations to prodrug firm Kempharm.
Samsung Bioepis has contracted Catalent to provide fill finish services for its Enbrel (etanercept) biosimilar, Benepali.
Nucleic acid manufacturer Nitto Denko Avecia has agreed to buy Irvine Pharmaceutical Services and Avrio Biopharmaceuticals in deals designed to expand its production business.
Merck has completed the expansion of its biologics API manufacturing facility in Madrid, Spain increasing production capacity by 50%.
BASF is confident the shutdown of its site in Ludwigshafen after an explosion on Monday will not disrupt the supply of drug excipients.